BMSN. the whole cell tech arena is being smothered by big pharm. Killing these small tech companies with patents and know-how but no product bringing in $$. They survive by diluting their stock.
FDA the culprit. Paper requirements bring further delay, draining them. When all is lost, big pharm steps in, getting patents AND know-how on the cheap. Then, all of a sudden, FDA approvals abound.
This has been very frustrating for the last 10 YEARS! Tech screams advancement in medicine, potential for good...and money to be made. Investors get in early, subsidizing these small companies hoping that they got in on the 'bottom floor' with profit galore when products and procedures come forth.
Little did they know that they only paid for all the ground work (so big pharms would not) with, in the end, nothing to show for it.
The tech is real. The problems that would be solved or drastically reduced by those receiving the benefits of cell tech TODAY, suffer needlessly. Wait...and pass away without relief.
TOMORROW, once big pharm has control of those benefits and procedures, people will benefit while the big pharm profit unbelievably.
Today's investor will NOT share in that profit. Business is heartless.
News 
Market Data 
Discover 
